Emergency Med Medical News about Antiplatelet

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Antiplatelet Medications: Old and Emerging Therapies
Annals of Vascular Surgery, 07/22/09

Stone WM et al. – Antiplatelet medications have been proven to enhance outcomes in patients with cardiovascular disease. The ideal platelet inhibitor would be quick and reversible and would have universal response, an excellent safety profile, and proven benefit. Currently available antiplatelet medications have been demonstrated to have variable patient response. In light of this medication resistance, emerging therapies to inhibit platelet aggregation are under investigation.

<< Previous
Long-Term Effects of Repealing the National Maximum Speed Limit...

Next >>
Injecting, Sexual Risk Behaviors and HIV Infection in Young...

Dual antiplatelet therapy in coronary artery disease: A case-based approach
Cleveland Clinic Journal of Medicine, 11/04/09 Relevance Score: 88%

Role of Antiplatelet Agents in Hematoma Expansion During The Acute Period of Intracerebral Hemorrhage
Neurocritical Care, 10/23/09 Relevance Score: 87%

Antiplatelet drugs and the perioperative period: What every urologist needs to know
Indian Journal of Urology, 10/05/09 Relevance Score: 87%

New antiplatelet agents: Why they are needed
European Journal of Internal Medicine, 11/09/09 Relevance Score: 85%

Antithrombotic and antiplatelet activities of fenofibrate, a lipid-lowering drug
Atherosclerosis, 10/07/09 Relevance Score: 84%